MRS and 11C-methionine PET/CT in the Diagnosis of Glioma

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

September 30, 2016

Study Completion Date

December 31, 2017

Conditions
Glioma
Interventions
OTHER

tumors are confirmed by surgery and pathology

Each patient undergoes both MRS and MET PET scan before surgery. The lesion will be considered as a glioma when either MRS or MET PET results indicated the diagnosis. Pathologic diagnosis will be performed to confirm the final diagnosis.

Trial Locations (1)

200040

Huashan hospital, Fudan university, Shanghai

All Listed Sponsors
lead

Huashan Hospital

OTHER

NCT03009318 - MRS and 11C-methionine PET/CT in the Diagnosis of Glioma | Biotech Hunter | Biotech Hunter